June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Metagenomic sequencing of Sjögren syndrome and healthy gut microbiota reveals differential bacterial species that correlate with disease severity
Author Affiliations & Notes
  • Laura Schaefer
    Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States
    Center of Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, United States
  • Firas S Midani
    Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States
    Center of Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, United States
  • Claudia M Trujillo-Vargas
    Grupo de Inmunodeficiencias Primarias, Universidad de Antioquia Facultad de Medicina, Medellin, Colombia
    Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States
  • Stephen C Pflugfelder
    Ophthalmology, Baylor College of Medicine, Houston, Texas, United States
  • Robert A Britton
    Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States
    Center of Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, United States
  • Cintia S De Paiva
    Ophthalmology, Baylor College of Medicine, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Laura Schaefer Mikrovia, Panabio, Tenza Inc., Code I (Personal Financial Interest); Firas Midani None; Claudia Trujillo-Vargas None; Stephen Pflugfelder Allergan, Dompe, Kala, Kowa, Novatis Pharma AG, Senju, Code C (Consultant/Contractor), Yuyu Pharma, Santen, Dompe, Code F (Financial Support); Robert Britton Tenza Inc., Code C (Consultant/Contractor), Mikrovia, Panabio, Tenza Inc., Code I (Personal Financial Interest); Cintia De Paiva Yuyu Pharma, Roche, Allysta, Code F (Financial Support)
  • Footnotes
    Support  NIH/NEI EY026893 (CSDP), NIH EY-002520 (Core Grant for Vision Research Department of Ophthalmology), Research to Prevent Blindness Stein Innovation Award (RAB), Research to Prevent Blindness (Dept. of Ophthalmology), The Hamill Foundation, The Sid Richardson Foundation
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3833. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Laura Schaefer, Firas S Midani, Claudia M Trujillo-Vargas, Stephen C Pflugfelder, Robert A Britton, Cintia S De Paiva; Metagenomic sequencing of Sjögren syndrome and healthy gut microbiota reveals differential bacterial species that correlate with disease severity. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3833.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A growing number of studies show that homeostasis of the ocular surface is impacted by the intestinal microbiome, and several 16S sequencing studies have demonstrated dysbiosis of the intestinal microbiota in Sjögren Syndrome (SS) patients. In this study, we utilized metagenomic sequencing to perform a deeper analysis of the intestinal microbiome to identify differential bacterial species using stools collected from sex- and age-matched subjects.

Methods : Age-matched healthy (n = 20), dry eye (n = 4) and SS (n = 7) female patients were enrolled at the BCM Alkek Eye Center. Ocular disease severity was scored following International Dry Eye Workshop guidelines. Patients were supplied with stool collection kits and submitted samples within 24 hours post-collection. High quality DNA was prepared for metagenomics sequencing from stool aliquots using DNEasy Powersoil Pro kits. Sequencing, annotation, and initial analysis were performed by Diversigen with their BoosterShot Shotgun Sequencing service. We further analyzed the data using the vegan and randomForest packages in R statistical software.

Results : Shannon alpha diversity and observed operational taxonomic units (OTUs) were significantly decreased in SS (P<0.05). Observed OTUs inversely correlated with ocular severity score (Spearman’s r=-0.37, P<0.05). Using Bray-Curtis beta diversity analysis, we found significant separation between healthy and SS groups (PERMANOVA R2=0.08, P<0.05), but not between healthy and dry eye groups. We investigated taxonomic differences using the Random Forest machine learning algorithm. At the phylum level, Bacteroidetes (P<0.05) and Actinobacteria (P<0.01) contributed the most to community differences. At the species level, SS patients were distinguished by significant increases in Bacteroides caecimuris, Mediterranea masilliensis, Bacteroides coprophilus and Clostridium_sp_7_3_54FAA and a significant decrease in Bifidobacterium bifidum compared to healthy controls (all P<0.01), and these species changes correlated with disease severity.

Conclusions : Our metagenomic data confirm that the SS gut microbiome is less diverse, and that reduced diversity correlates with increased ocular disease severity. In addition, we have identified specific bacterial species that are either depleted or enriched in SS patients and correlate with ocular surface disease severity.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×